No Data
Top FDA Vaccine Official Resigns Citing RFK Jr.'s 'Misinformation and Lies'
Carnival Adds Ships in Australia Amid Strong Local Demand
Pfizer Ran What Could Be the Largest Tax Dodging Scheme Among Big Pharma: Senator
Merck Subcutaneous Keytruda Gains FDA Target Date in September
Cruise Line Check: Carnival, Royal Caribbean, and Viking Attract Bull Ratings at BNP Paribas
Merck's Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared To Intravenous KEYTRUDA In Pivotal 3475A-D77 Trial; A Time And Motion Descriptive Analysis Shows Nearly 50% Reductions In...
